Massachusetts-based Analogic (NSDQ:ALOG) missed the mark in its 1st-quarter sales and earnings, falling short of analysts’ estimates and diving into the red amid sinking sales.
Analogic
Covidien CEO Almeida wants more from emerging markets | Wall Street Beat
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Analogic announces 140 layoffs as it integrates Ultrasonix Medical
Hologic hits 52-week high on mammography study | Wall Street Beat
Hologic (NSDQ:HOLX) shares hit a 52-week high yesterday on news that mammography using 3D technology significantly improved diagnostic accuracy.
HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.
CareFusion delays annual report, gets delisting NYSE warning | Wall Street Beat
CareFusion (NYSE:CFN) shares are down slightly today after the medical device company said it would be late in filing its annual report with the SEC, which triggered a delisting warning from the New York Stock Exchange.
CareFusion said it’s negotiating with the securities regulator over how to account for leases of its Pyxis medicine dispensing devices.
Medical Device Tax: Ten companies in line for a whack
The medical device tax set to take effect next year as part of the Affordable Care Act will see all medical device companies pay a 2.3% levy on U.S. sales. But the tax is likely to strike some companies a lot harder where it hurts the most: the bottom line.
Globus Medical files for IPO | Wall Street Beat
Globus Medical filed for an initial public offering yesterday, saying it’s planning a reverse split of its existing stock just before the IPO launches.
The Audubon, Pa.-based orthopedic device maker, which ran afoul of the FDA last month, said it hopes to trade under the "GMED" ticker on the New York Stock Exchange.
Piper Jaffray: Abiomed wins reimbursement code | Wall Street Beat
Abiomed (NSDQ:ABMD) is slated to win a reimbursement code for procedures involving its Impella heart pump, according to analysts at Piper Jaffray.
In a summary of recent editorial panel decisions, the American Medical Assn. revealed that the panel approved the Society for Cardiovascular Angiography and Interventions’ proposal for the reimbursement code, according to theflyonthewall.com.
AGFA Gevaert slides to Q4, 2011 red | Earnings Roundup
AGFA Gevaert slides to Q4, 2011 red
AGFA Gevaert (EBR:AGFB) swung to red ink for the 4th quarter and 2011.
Stryker ex-CEO MacMillan resigns from Texas Instruments board | Personnel Moves
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.
KCI taps new CEOs, chairman | Personnel Moves
Newly privatized Kinetic Concepts Inc. is shuffling the deck, naming a new chairman, new CEOs for two of its businesses and announcing plans to spin out a third.
The wound care giant was taken private in a $6.1 billion leveraged buyout last year by Apax Partners and a pair of Canadian pension funds.